Literature DB >> 30319773

A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation score.

Lisa B VanWagner1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30319773      PMCID： PMC6178958          DOI： 10.1002/cld.718

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  13 in total

1.  Cumulative risk of cardiovascular events after orthotopic liver transplantation.

Authors:  Mazen Albeldawi; Ashish Aggarwal; Surabhi Madhwal; Jacek Cywinski; Rocio Lopez; Bijan Eghtesad; Nizar N Zein
Journal:  Liver Transpl       Date:  2012-03       Impact factor: 5.799

2.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Authors:  David Goldberg; Ivo C Ditah; Kia Saeian; Mona Lalehzari; Andrew Aronsohn; Emmanuel C Gorospe; Michael Charlton
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

3.  A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

Authors:  Lisa B VanWagner; Hongyan Ning; Maureen Whitsett; Josh Levitsky; Sarah Uttal; John T Wilkins; Michael M Abecassis; Daniela P Ladner; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 4.  Keys to long-term care of the liver transplant recipient.

Authors:  Kymberly D Watt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

5.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

6.  Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.

Authors:  Samarth S Patel; Eiman Nabi; Luis Guzman; Antonio Abbate; Chandra Bhati; Richard T Stravitz; Trevor Reichman; Scott C Matherly; Carolyn Driscoll; Hannah Lee; Velimir A Luketic; Richard K Sterling; Arun J Sanyal; Vaishali Patel; Marlon Levy; Mohammad Shadab Siddiqui
Journal:  Liver Transpl       Date:  2018-03       Impact factor: 5.799

7.  The impact of obesity on patient survival in liver transplant recipients: a meta-analysis.

Authors:  Sammy Saab; David Lalezari; Paridhima Pruthi; Theodore Alper; Myron J Tong
Journal:  Liver Int       Date:  2014-01-07       Impact factor: 5.828

8.  Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.

Authors:  Lynn A Fussner; Julie K Heimbach; Chun Fan; Ross Dierkhising; Elizabeth Coss; Michael D Leise; Kymberly D Watt
Journal:  Liver Transpl       Date:  2015-07       Impact factor: 5.799

9.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

10.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086
View more
  2 in total

Review 1.  PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient.

Authors:  Brett Sadowski; Tilak Baba; Amol S Rangnekar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 2.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.